World Heart Federation Consensus on Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM)
Transthyretin amyloid cardiomyopathy (ATTR-CM) is a progressive and fatal condition that requires early diagnosis, management, and specific treatment. The availability of new disease-modifying therapies has made successful treatment a reality. Transthyretin amyloid cardiomyopathy can be either age-r...
Saved in:
Main Authors: | Dulce Brito (Chair) (Author), Fabiano Castro Albrecht (Author), Diego Perez de Arenaza (Author), Nicole Bart (Author), Nathan Better (Author), Isabel Carvajal-Juarez (Author), Isabel Conceição (Author), Thibaud Damy (Author), Sharmila Dorbala (Author), Jean-Christophe Fidalgo (Author), Pablo Garcia-Pavia (Author), Junbo Ge (Author), Julian D. Gillmore (Author), Jacek Grzybowski (Author), Laura Obici (Author), Daniel Piñero (Author), Claudio Rapezzi (Author), Mitsuharu Ueda (Author), Fausto J. Pinto (Author) |
---|---|
Format: | Book |
Published: |
Ubiquity Press,
2023-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Diagnosis and Screening of Patients with Hereditary Transthyretin Amyloidosis (hATTR): Current Strategies and Guidelines
by: Benson MD, et al.
Published: (2020) -
Diagnosis and Treatment of Hereditary Transthyretin Amyloidosis (hATTR) Polyneuropathy: Current Perspectives on Improving Patient Care
by: Luigetti M, et al.
Published: (2020) -
Early identification of cardiac ATTR amyloidosis: a clinical case
by: A. A. Vedernikov, et al.
Published: (2024) -
Systemic ATTR-amyloidosis, a Rare Form of Internal Organ Damage
by: V. V. Rameev, et al.
Published: (2019) -
Transthyretin Amyloidosis Therapies: Guiding the Future
by: Alejandra González-Duarte
Published: (2021)